Clinical trials
Blood Coagulation Disorders trials in Spain
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
19 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 1 |
| 2013 | 2 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 1 |
| 2023 | 3 |
| 2024 | 1 |
| 2025 | 4 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 11 |
| Recruiting | 2 |
| Active, not recruiting | 2 |
| Withdrawn | 1 |
| Terminated | 1 |
| Unknown status | 1 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Swedish Orphan Biovitrum | 7 |
| BioMarin Pharmaceutical | 2 |
| Genzyme, a Sanofi Company | 2 |
| Bayer | 1 |
| European Society of Anaesthesiology | 1 |
| Hospital General Universitario Gregorio Marañon | 1 |
| Hospital Universitario La Paz | 1 |
| Hutchmed | 1 |
| Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz | 1 |
| Kedrion S.p.A. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Blood Coagulation Disorders | 19 |
| Coagulation Protein Disorders | 11 |
| Hemophilia A | 11 |
| Hematologic Diseases | 9 |
| Hemorrhagic Disorders | 9 |
| Genetic Diseases, Inborn | 6 |
| Blood Coagulation Disorders, Inherited | 4 |
| Hemophilia B | 4 |
| Hemostatic Disorders | 3 |
| Autoimmune Diseases | 2 |
Trials
Showing 26 to 19 of 19. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.